NVST
Envista Holdings Corp
-0.83 (-3.32%)24.14USD1.8M成交股數3.9B市值41.6本益比(近四季)1.4股價營收比+7.1%營收年增(近四季)2026-10-28下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 1 · 220K · 1 |
| 其中 10b5-1 計畫賣出 | 1 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 220K |
| 近 180 天 淨額 | −220K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-25 | 08-27 | Nilsson Stefan | President, Nobel Biocare | F 繳稅扣股 | 804 | 27.47 | 22K | 61.6K | SEC |
| 2026-08-25 | 08-27 | Befidi Robert | President, Diagnostics | F 繳稅扣股 | 5.1K | 27.47 | 141K | 45.8K | SEC |
| 2026-08-25 | 08-27 | Acurio Veronica | President, Orthodontics | F 繳稅扣股 | 7.7K | 27.47 | 212K | 48.8K | SEC |
| 2026-08-25 | 08-27 | Hammes Eric D. | Chief Financial Officer | F 繳稅扣股 | 10.9K | 27.47 | 299K | 99.9K | SEC |
| 2026-08-20 | 08-24 | Reis Mischa | SVP, Strategy & Bus. Dev. | S 公開市場賣出(10b5-1) | 8.0K | 27.50 | 220K | 27.3K | SEC |
| 2026-08-18 | 08-20 | Keel Paul A | Chief Executive Officer | A 獲配股票 | 180K | – | – | 551K | SEC |
| 2026-05-25 | 05-27 | Keel Paul A | Chief Executive Officer | F 繳稅扣股 | 12.8K | 23.43 | 300K | 372K | SEC |
| 2026-05-19 | 05-21 | TSINGOS CHRISTINE A | Director | A 獲配股票 | 9.3K | – | – | 59.9K | SEC |
| 2026-05-19 | 05-21 | Carruthers Wendy | Director | A 獲配股票 | 9.3K | – | – | 59.9K | SEC |
| 2026-05-19 | 05-21 | GALLAHUE KIERAN | Director | A 獲配股票 | 9.3K | – | – | 54.0K | SEC |
| 2026-05-19 | 05-21 | Jain Vivek | Director | A 獲配股票 | 9.3K | – | – | 52.9K | SEC |
| 2026-05-19 | 05-21 | Raskas Daniel | Director | A 獲配股票 | 9.3K | – | – | 54.0K | SEC |
| 2026-05-19 | 05-21 | Pierce James Andrew | Director | A 獲配股票 | 9.3K | – | – | 18.5K | SEC |
| 2026-05-19 | 05-21 | Huennekens R Scott | Director | A 獲配股票 | 12.6K | – | – | 82.1K | SEC |
| 2026-02-25 | 02-27 | Nilsson Stefan | President, Nobel Biocare | F 繳稅扣股 | 182 | 29.59 | 5K | 54.8K | SEC |
| 2026-02-25 | 02-27 | Kaabi Faez C | Chief Accounting Officer | A 獲配股票 | 13.5K | – | – | 58.6K | SEC |
| 2026-02-25 | 02-27 | Acurio Veronica | President, Orthodontics | F 繳稅扣股 | 1.4K | 29.59 | 42K | 48.9K | SEC |
| 2026-02-25 | 02-27 | Befidi Robert | President, Diagnostics | A 獲配股票 | 7.6K | – | – | 50.9K | SEC |
| 2026-02-25 | 02-27 | Hammes Eric D. | Chief Financial Officer | F 繳稅扣股 | 2.0K | 29.59 | 61K | 94.7K | SEC |
| 2026-02-25 | 02-27 | Befidi Robert | President, Diagnostics | F 繳稅扣股 | 2.2K | 29.59 | 64K | 43.3K | SEC |
| 2026-02-25 | 02-27 | Kaabi Faez C | Chief Accounting Officer | F 繳稅扣股 | 5.0K | 29.59 | 147K | 45.0K | SEC |
| 2026-02-25 | 02-27 | Reis Mischa | SVP, Strategy & Bus. Dev. | A 獲配股票 | 5.9K | – | – | 35.3K | SEC |
| 2026-02-25 | 02-27 | Nance Mark E | General Counsel | A 獲配股票 | 12.7K | – | – | 81.3K | SEC |
| 2026-02-25 | 02-27 | Keel Paul A | Chief Executive Officer | A 獲配股票 | 48.7K | – | – | 384K | SEC |
| 2026-02-25 | 02-27 | Hammes Eric D. | Chief Financial Officer | A 獲配股票 | 16.1K | – | – | 111K | SEC |
| 2026-02-25 | 02-27 | Nilsson Stefan | President, Nobel Biocare | A 獲配股票 | 7.6K | – | – | 62.4K | SEC |
| 2026-02-25 | 02-27 | Reis Mischa | SVP, Strategy & Bus. Dev. | F 繳稅扣股 | 3.0K | 29.59 | 88K | 29.4K | SEC |
| 2026-02-25 | 02-27 | Nance Mark E | General Counsel | F 繳稅扣股 | 3.4K | 29.59 | 100K | 68.6K | SEC |
| 2026-02-25 | 02-27 | Keel Paul A | Chief Executive Officer | F 繳稅扣股 | 11.8K | 29.59 | 350K | 336K | SEC |
| 2026-02-25 | 02-27 | Acurio Veronica | President, Orthodontics | A 獲配股票 | 7.6K | – | – | 56.5K | SEC |
| 2026-02-10 | 02-11 | Reis Mischa | SVP, Strategy & Bus. Dev. | M 選擇權執行 | 4.0K | 19.04 | 77K | 36.4K | SEC |
| 2026-02-10 | 02-11 | Reis Mischa | SVP, Strategy & Bus. Dev. | S 公開市場賣出(10b5-1) | 4.0K | 30.00 | 121K | 32.4K | SEC |
| 2026-02-10 | 02-11 | Reis Mischa | SVP, Strategy & Bus. Dev. | S 公開市場賣出(10b5-1) | 5.6K | 30.00 | 169K | 32.4K | SEC |
| 2026-02-10 | 02-11 | Reis Mischa | SVP, Strategy & Bus. Dev. | M 選擇權執行 | 5.6K | 15.97 | 90K | 38.0K | SEC |
| 2025-11-01 | 11-04 | Keel Paul A | Chief Executive Officer | F 繳稅扣股 | 54.1K | 20.35 | 1.1M | 348K | SEC |
| 2025-08-25 | 08-27 | Acurio Veronica | President, Orthodontics | F 繳稅扣股 | 5.4K | 21.12 | 115K | 50.3K | SEC |
| 2025-08-25 | 08-27 | Reis Mischa | SVP, Strategy & Bus. Dev. | S 公開市場賣出(10b5-1) | 15.0K | 21.60 | 324K | 32.4K | SEC |
| 2025-08-25 | 08-27 | Hammes Eric D. | Chief Financial Officer | F 繳稅扣股 | 7.7K | 21.12 | 162K | 96.8K | SEC |
| 2025-08-25 | 08-27 | Nilsson Stefan | President, Nobel Biocare | F 繳稅扣股 | 804 | 21.12 | 17K | 54.9K | SEC |
| 2025-08-25 | 08-27 | Befidi Robert | President, Diagnostics | F 繳稅扣股 | 3.5K | 21.12 | 73K | 45.5K | SEC |
| 2025-07-14 | 07-16 | Pierce James Andrew | Director | A 獲配股票 | 9.2K | – | – | 9.2K | SEC |
| 2025-06-10 | 06-12 | GALLAHUE KIERAN | Director | A 獲配股票 | 10.4K | – | – | 44.7K | SEC |
| 2025-06-10 | 06-12 | Huennekens R Scott | Director | A 獲配股票 | 14.4K | – | – | 69.5K | SEC |
| 2025-06-10 | 06-12 | Raskas Daniel | Director | A 獲配股票 | 10.4K | – | – | 44.7K | SEC |
| 2025-06-10 | 06-12 | Jain Vivek | Director | A 獲配股票 | 10.4K | – | – | 43.6K | SEC |
| 2025-06-10 | 06-12 | Carruthers Wendy | Director | A 獲配股票 | 10.4K | – | – | 50.6K | SEC |
| 2025-06-10 | 06-12 | TSINGOS CHRISTINE A | Director | A 獲配股票 | 10.4K | – | – | 50.6K | SEC |
| 2025-06-10 | 06-12 | Hulit Barbara B. | Director | A 獲配股票 | 10.4K | – | – | 79.8K | SEC |
| 2025-05-25 | 05-27 | Keel Paul A | Chief Executive Officer | F 繳稅扣股 | 12.8K | 16.72 | 214K | 402K | SEC |
| 2025-02-26 | 02-27 | Reis Mischa | SVP, Strategy & Bus. Dev. | A 獲配股票 | 8.5K | – | – | 47.4K | SEC |
| 2025-02-25 | 02-27 | Acurio Veronica | President, Orthodontics | A 獲配股票 | 10.3K | – | – | 55.7K | SEC |
| 2025-02-25 | 02-27 | Kaabi Faez C | Chief Accounting Officer | A 獲配股票 | 9.7K | – | – | 50.0K | SEC |
| 2025-02-25 | 02-27 | Nance Mark E | General Counsel | A 獲配股票 | 18.2K | – | – | 71.9K | SEC |
| 2025-02-25 | 02-27 | Reis Mischa | SVP, Strategy & Bus. Dev. | F 繳稅扣股 | 3.8K | 20.66 | 79K | 38.9K | SEC |
| 2025-02-25 | 02-27 | Keel Paul A | Chief Executive Officer | A 獲配股票 | 65.8K | – | – | 414K | SEC |
| 2025-02-25 | 02-27 | Nance Mark E | General Counsel | F 繳稅扣股 | 3.7K | 20.66 | 76K | 53.8K | SEC |
| 2025-02-25 | 02-27 | Nilsson Stefan | President, Nobel Biocare | A 獲配股票 | 10.3K | – | – | 55.7K | SEC |
| 2025-02-25 | 02-27 | Befidi Robert | President, Diagnostics | A 獲配股票 | 10.3K | – | – | 49.0K | SEC |
| 2025-02-25 | 02-27 | Befidi Robert | President, Diagnostics | F 繳稅扣股 | 1.1K | 20.66 | 23K | 38.7K | SEC |
| 2025-02-25 | 02-27 | Hammes Eric D. | Chief Financial Officer | A 獲配股票 | 15.7K | – | – | 104K | SEC |
| 2025-02-25 | 02-27 | Kaabi Faez C | Chief Accounting Officer | F 繳稅扣股 | 4.3K | 20.66 | 89K | 40.3K | SEC |
| 2024-11-01 | 11-04 | Keel Paul A | Chief Executive Officer | F 繳稅扣股 | 54.0K | 20.94 | 1.1M | 349K | SEC |
| 2024-09-17 | 09-19 | Reis Mischa | SVP, Strategy & Bus. Dev. | F 繳稅扣股 | 812 | 19.00 | 15K | 42.7K | SEC |
| 2024-08-25 | 08-27 | Hammes Eric D. | Chief Financial Officer | A 獲配股票 | 64.2K | – | – | 88.7K | SEC |
| 2024-08-25 | 08-27 | Befidi Robert | President, Diagnostics | F 繳稅扣股 | 3.5K | 18.70 | 65K | 39.8K | SEC |
| 2024-08-13 | 08-14 | Keel Paul A | Chief Executive Officer | P 公開市場買進 | 30.0K | 16.87 | 506K | 403K | SEC |
| 2024-08-12 | 08-13 | Hammes Eric D. | Chief Financial Officer | P 公開市場買進 | 24.5K | 16.33 | 401K | 24.5K | SEC |
| 2024-07-15 | 07-17 | Nance Mark E | General Counsel | F 繳稅扣股 | 491 | 15.94 | 8K | 57.5K | SEC |
| 2024-06-25 | 06-27 | Keller Stephen | Principal Financial Officer | A 獲配股票 | 31.3K | – | – | 53.8K | SEC |
| 2024-05-25 | 05-29 | Keel Paul A | Chief Executive Officer | A 獲配股票 | 71.2K | – | – | 71.2K | SEC |
| 2024-05-25 | 05-29 | Conley Eric | SVP, Orthodontics | F 繳稅扣股 | 642 | 18.25 | 12K | 53.2K | SEC |
| 2024-05-25 | 05-29 | Keel Paul A | Chief Executive Officer | A 獲配股票 | 301K | – | – | 373K | SEC |
| 2024-05-21 | 05-23 | Jain Vivek | Director | A 獲配股票 | 10.1K | – | – | 33.2K | SEC |
| 2024-05-21 | 05-23 | GALLAHUE KIERAN | Director | A 獲配股票 | 10.1K | – | – | 34.2K | SEC |
| 2024-05-21 | 05-23 | Carruthers Wendy | Director | A 獲配股票 | 10.1K | – | – | 40.2K | SEC |
| 2024-05-21 | 05-23 | Raskas Daniel | Director | A 獲配股票 | 10.1K | – | – | 34.2K | SEC |
| 2024-05-21 | 05-23 | Hulit Barbara B. | Director | A 獲配股票 | 10.1K | – | – | 69.4K | SEC |
| 2024-05-21 | 05-23 | Huennekens R Scott | Director | A 獲配股票 | 14.2K | – | – | 55.1K | SEC |
| 2024-05-21 | 05-23 | TSINGOS CHRISTINE A | Director | A 獲配股票 | 10.1K | – | – | 40.1K | SEC |
| 2024-04-15 | 04-16 | Hulit Barbara B. | Director | A 獲配股票 | 13.1K | – | – | 59.3K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 18.4M | 486M | 新進 | 新進 |
| ARIEL INVESTMENTS, LLC | 9.8M | 259M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 9.6M | 252M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 7.5M | 197M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 7.3M | 193M | 新進 | 新進 |
| MORGAN STANLEY | 6.4M | 170M | 新進 | 新進 |
| Gates Capital Management, Inc. | 5.6M | 146M | 新進 | 新進 |
| STATE STREET CORP | 5.3M | 140M | 新進 | 新進 |
| ALLIANCEBERNSTEIN L.P. | 5.2M | 132M | 新進 | 新進 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 4.8M | 128M | 新進 | 新進 |
| FRANKLIN RESOURCES INC | 4.8M | 127M | 新進 | 新進 |
| VICTORY CAPITAL MANAGEMENT INC | 4.5M | 118M | 新進 | 新進 |
| Ilex Capital Partners (UK) LLP | 4.4M | 115M | 新進 | 新進 |
| Quantinno Capital Management LP | 4.2M | 111M | 新進 | 新進 |
| AQR CAPITAL MANAGEMENT LLC | 4.0M | 106M | 新進 | 新進 |
| NEUBERGER BERMAN GROUP LLC | 3.9M | 102M | 新進 | 新進 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 3.6M | 96.0M | 新進 | 新進 |
| JPMORGAN CHASE & CO | 3.3M | 89.5M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.2M | 83.0M | 新進 | 新進 |
| AMERICAN CENTURY COMPANIES INC | 3.1M | 80.4M | 新進 | 新進 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2.9M | 78.5M | 新進 | 新進 |
| HARRIS ASSOCIATES L P | 2.8M | 72.6M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 2.7M | 72.3M | 新進 | 新進 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2.2M | 58.2M | 新進 | 新進 |
| UBS Group AG | 2.1M | 55.9M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 382 -10 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 382 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 190M · 100.0% |
| 合計季末市值 | 5.0B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 11.4M |
|---|---|
| 與上期比 | +18.1% |
| 佔流通股數 | 7.09% |
| 日均成交量 | 2.1M |
| 回補天數 | 5.5 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 11.4M | +18.1% | 7.09% | 2.1M | 5.5 |
| 2026-08-14 | 9.6M | -19.0% | 6.00% | 3.7M | 2.6 |
| 2026-07-31 | 11.9M | +27.0% | 7.40% | 2.6M | 4.6 |
| 2026-07-15 | 9.4M | -4.8% | 5.83% | 2.8M | 3.4 |
| 2026-06-30 | 9.8M | -18.7% | 6.12% | 2.7M | 3.6 |
| 2026-06-15 | 12.1M | +2.2% | 7.54% | 2.6M | 4.6 |
| 2026-05-29 | 11.8M | +3.8% | 7.38% | 4.3M | 2.7 |
| 2026-05-15 | 11.4M | +20.9% | 7.11% | 4.2M | 2.7 |
| 2026-04-30 | 9.4M | -14.3% | 5.88% | 2.4M | 4.0 |
| 2026-04-15 | 11.0M | +13.7% | 6.86% | 2.0M | 5.5 |
| 2026-03-31 | 9.7M | +32.8% | 6.03% | 2.4M | 4.1 |
| 2026-03-13 | 7.3M | -2.9% | 4.54% | 2.5M | 2.9 |
| 2026-02-27 | 7.5M | -5.7% | 4.68% | 2.7M | 2.8 |
| 2026-02-13 | 8.0M | -1.5% | 4.96% | 5.0M | 1.6 |
| 2026-01-30 | 8.1M | -23.3% | 5.04% | 2.6M | 3.1 |
| 2026-01-15 | 10.5M | +0.9% | 6.57% | 2.4M | 4.4 |
| 2025-12-31 | 10.4M | +7.0% | 6.50% | 2.2M | 4.8 |
| 2025-12-15 | 9.8M | -7.8% | 6.08% | 2.3M | 4.2 |
| 2025-11-28 | 10.6M | -1.7% | 6.59% | 1.7M | 6.4 |
| 2025-11-14 | 10.8M | +0.0% | 6.70% | 2.1M | 5.2 |
| 2025-10-31 | 10.8M | +4.9% | 6.70% | 2.3M | 4.7 |
| 2025-10-15 | 10.3M | +12.7% | 6.39% | 2.0M | 5.1 |
| 2025-09-30 | 9.1M | -11.2% | 5.67% | 2.2M | 4.2 |
| 2025-09-15 | 10.2M | +5.8% | 6.38% | 1.6M | 6.5 |
| 2025-08-29 | 9.7M | -6.1% | 6.03% | 1.5M | 6.6 |
| 2025-08-15 | 10.3M | +9.8% | 6.42% | 2.7M | 3.9 |